The value of PD-L1 as a biomarker beyond lung cancers

Date 27 September 2019
Event ESMO 2019 Congress
Session Current markers in immunotherapy
Topics Urothelial Cancers
Immunotherapy
Hepatobiliary Cancers
Cancer Biology
Gastrointestinal Cancers
Genitourinary Cancers
Head and Neck Cancers
Therapy
Presenter Kevin Harrington
Authors K.J. Harrington
  • Radiotherapy & Imaging, Institute of Cancer Research ICR, SW3 6JB - London/GB